We could conclude that WZY compounds affect AD primarily through binding to node proteins of serotonergic synapse signaling (SLC6A4), hormones (PTGS2, ESR1, AR), inflammation (SRC, TNF, NOS3), transcription regulation (NR3C1), and molecular chaperones (HSP90AA1). Here, NR3C1 is linked to Alzheimer disease.